AGM
VIVO

Alpine Global Management’s Meridian Bioscience Inc VIVO Stock Holding History

Alpine Global Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,952
Closed -$156K – 494
2019
Q4 		$156K Buy
+15,952
New +$150K 0.03% 335

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alpine Global Management's VIVO Position: Q1 2020 in Review

Alpine Global Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2020, closing a stake of 15,952 shares — an estimated $156K sold.

Alpine Global Management first reported a position in VIVO in Q4 2019 and held it in 1 quarter. The position peaked at $156K in Q4 2019. 168 funds tracked by Wall St. Rank hold VIVO as of Q1 2020.

  • Alpine Global Management reported no remaining Meridian Bioscience Inc position as of Q1 2020 after selling out during the quarter.
  • Alpine Global Management sold 15,952 Meridian Bioscience Inc shares in Q1 2020, an estimated $156K.
  • Alpine Global Management first reported a position in Meridian Bioscience Inc in Q4 2019 and held it in 1 quarter.
  • Alpine Global Management's Meridian Bioscience Inc position peaked at $156K in Q4 2019.
  • 168 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2020.

Based on Alpine Global Management's 13F filing for Q1 2020, filed 9 Apr 2020.